Change search criteria ↓

Search results

108 projects found matching your search criteria:

  1. 1. New receptors for C-reactive protein recognition - generation, characterization and application towards fast differentia…

    Principal investigator: dr Katarzyna Szot-Karpińska

    Instytut Chemii Fizycznej Polskiej Akademii Nauk

    Call: SONATA 13, Panel: ST5

  2. 2. Modulation of inflammatory processes using new agonists of the formyl peptide receptors ALX/FPR2 as a new therapeutic st…

    Principal investigator: prof. Agnieszka Basta-Kaim

    Instytut Farmakologii PAN

    Call: HARMONIA 9, Panel: NZ7

  3. 3. Search for new "drug-like" molecules designed as adenosine receptors ligands

    Principal investigator: prof. Katarzyna Justyna Kieć-Kononowicz

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

    Call: HARMONIA 2, Panel: NZ4

  4. 4. Adopted orphan nuclear receptors as new regulators of testis immune privilege

    Principal investigator: dr Alicja Kinga Kamińska

    Uniwersytet Jagielloński

    Call: SONATA 20, Panel: NZ3

  5. 5. The role of simultaneous and individual modulation of μ-opioid, sigma-1 and histamine H3 receptors as a new therapeutic …

    Principal investigator: dr Katarzyna Anna Szczepańska

    Instytut Farmakologii PAN

    Call: OPUS 23, Panel: NZ7

  6. 6. Dual histamine H3 and sigma-1 receptor ligands as novel pharmacological tools in the treatment of central nervous system…

    Principal investigator: dr Katarzyna Anna Szczepańska

    Instytut Farmakologii PAN

    Call: SONATINA 4, Panel: NZ7

  7. 7. New selective antagonists of ionotropic glutamate non-NMDA receptors

    Principal investigator: dr Ewa Monika Szymańska

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

    Call: OPUS 8, Panel: NZ7

  8. 8. PHARMACOTHERAPY OF OSTEOARTHRITIS: TRPV1 AND CB1 RECEPTORS AND THEIR ENDOGENOUS LIGANDS AS NEW TARGETS FOR PHARMACOLOGIC…

    Principal investigator: dr hab. Katarzyna Maria Starowicz-Bubak

    Instytut Farmakologii PAN

    Call: SONATA BIS 2, Panel: NZ7

  9. 9. Novel ligands of histamine receptor H4 as potential anti-allergic and anti-inflammatory drugs

    Principal investigator: prof. Sławomir Hubert Filipek

    Uniwersytet Warszawski, Wydział Chemii

    Call: OPUS 13, Panel: NZ7

  10. 10. Synthesis of new macrocyclic molecular receptors with torand skeleton for selective and effective metal cation detection

    Principal investigator: Stanisław Marek Kulczyk

    Politechnika Warszawska

    Call: PRELUDIUM 24, Panel: ST5

  11. 11. The role of free fatty acid receptors in pathophysiology of the functional gastrointestinal tract disorders: new therapi…

    Principal investigator: dr hab. Maciej Stanisław Sałaga

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski

    Call: PRELUDIUM BIS 5, Panel: NZ7

  12. 12. Targeting the serotonin 5-HT7 receptor in a search for new strategies of mental disorders treatment

    Principal investigator: Patryk Pyka

    Uniwersytet Jagielloński, Collegium Medicum

    Call: PRELUDIUM 22, Panel: NZ7

  13. 13. Novel combination therapies of pulmonary arterial hypertension targeting blockade of peripheral cannabinoid CB1 receptor…

    Principal investigator: prof. Barbara Malinowska

    Uniwersytet Medyczny w Białymstoku

    Call: OPUS 21, Panel: NZ7

  14. 14. Selective activation of non-nuclear Estrogen Receptor signaling with PaPE-1 as a novel therapeutic approach for sporadic…

    Principal investigator: prof. Małgorzata Kajta

    Instytut Farmakologii PAN

    Call: OPUS 20, Panel: NZ7

  15. 15. Investigation of novel functionally selective opioid receptors agonists

    Principal investigator: Łucja Elżbieta Szumiec

    Instytut Farmakologii PAN

    Call: ETIUDA 8, Panel: NZ7

  16. 16. Specific interactions of new antitumor unsymmetrical bisacridines, UAs, with DNA and ABC proteins and their potential to…

    Principal investigator: prof. Zofia Mazerska

    Politechnika Gdańska

    Call: OPUS 17, Panel: NZ7

  17. 17. Evaluation of therapeutic role of novel positive allosteric modulators of GABA-A receptor in ischemic brain stroke

    Principal investigator: dr Monika Emilia Marcinkowska

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum

    Call: SONATA BIS 8, Panel: NZ7

  18. 18. Molecular characterisation of novel mutations in the gene encoding the luteinizing hormone/choriogonadotropin receptor (…

    Principal investigator: dr Kamila Julita Adamczuk

    Uniwersytet Medyczny w Lublinie

    Call: PRELUDIUM 15, Panel: NZ5

  19. 19. STIM proteins as new regulators of NMDA receptor trafficking in neurons

    Principal investigator: dr Joanna Edyta Gruszczyńska-Biegała

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

    Call: SONATA BIS 7, Panel: NZ3

  20. 20. Analysis and evaluation of the effectiveness of anorexic and safety properties for the new histamine H3 receptor ligands

    Principal investigator: dr hab. Magdalena Bogumiła Kotańska

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

    Call: OPUS 12, Panel: NZ7

  21. 21. Functional selectivity of novel histamine H4 receptor ligands

    Principal investigator: Agnieszka Urszula Olejarz-Maciej

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

    Call: PRELUDIUM 12, Panel: NZ7

  22. 22. New mulitple target-directed ligands - A1/A2A adenosine receptors antagonists and monoamine oxidase B inhibitors - searc…

    Principal investigator: Michał Karol Załuski

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

    Call: PRELUDIUM 12, Panel: NZ7

  23. 23. Biased inverse agonists of 5-HT6 receptor and dual 5-HT6/MAO-B inhibitors - in search for new therapeutic approaches for…

    Principal investigator: prof. Paweł Maria Zajdel

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

    Call: OPUS 11, Panel: NZ7

  24. 24. Search for the functionally selective 5-HT1A receptor agonists as new pharmacological tools in the development of treatm…

    Principal investigator: prof. Marcin Roman Kołaczkowski

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

    Call: OPUS 10, Panel: NZ7

  25. 25. Searching for the new lead structures for 5-HT7 serotonin receptor ligands with increased metabolic stability.

    Principal investigator: Sabina Marta Podlewska

    Instytut Farmakologii PAN

    Call: HARMONIA 7, Panel: NZ7

  26. 26. A comparative evaluation of effectiveness of phosphorothioate and phosphodiester lysophosphatidylcholine analogues in re…

    Principal investigator: Anna Katarzyna Drzazga

    Politechnika Łódzka, Wydział Biotechnologii i Nauk o Żywności

    Call: PRELUDIUM 6, Panel: NZ5

  27. 27. Identification and characterization of the new receptors for Salmonella enterica and its role in pathogenesis and Salmon…

    Principal investigator: dr Krzysztof Grzymajło

    Uniwersytet Przyrodniczy we Wrocławiu, Wydział Medycyny Weterynaryjnej

    Call: SONATA 5, Panel: NZ6

  28. 28. Obtaining of new quinoline derivatives with potential activity for serotonin receptors and inhibition of serotonin reupt…

    Principal investigator: Przemysław Paweł Taciak

    Warszawski Uniwersytet Medyczny, Wydział Farmaceutyczny z Oddziałem Medycyny Laboratoryjnej

    Call: PRELUDIUM 5, Panel: NZ7

  29. 29. Novel C3 symmetric triptycene derivatives useful for construction of artificial anion receptors

    Principal investigator: dr Jarosław Marek Granda

    Instytut Chemii Organicznej Polska Akademia Nauk

    Call: PRELUDIUM 4, Panel: ST5

  30. 30. Synthesis of new glutamate receptors antagonists and extensive investigation of their effect on tumor cells in the prese…

    Principal investigator: prof. Maria Wanda Bretner

    Politechnika Warszawska, Wydział Chemiczny

    Call: OPUS 9, Panel: ST5

  31. 31. Flavonoid phytoprogestins as novel non-steroidal progesterone receptor modulators in a nutraceutical approach to endomet…

    Principal investigator: Agata Gołąbek-Grenda

    Uniwersytet Przyrodniczy w Poznaniu

    Call: PRELUDIUM 24, Panel: NZ9

  32. 32. Cholesin and its receptor as novel therapeutic and diagnostic targets in metabolic disorders

    Principal investigator: prof. Wojciech Fendler

    Uniwersytet Medyczny w Łodzi

    Call: OPUS 29, Panel: NZ7

  33. 33. Novel tricyclic glycomimetics as DC-SIGN receptor ligands.

    Principal investigator: dr Mykhaylo Potopnyk

    Instytut Chemii Organicznej Polska Akademia Nauk

    Call: OPUS 22, Panel: ST4

  34. 34. New 5-HT6 receptor ligands from the group of sulfonamide derivatives of cyclic arylguanidines in the treatment of gliobl…

    Principal investigator: dr Przemysław Patryk Zaręba

    Politechnika Krakowska im. Tadeusza Kościuszki, Wydział Inżynierii i Technologii Chemicznej

    Call: PRELUDIUM 19, Panel: NZ7

  35. 35. New mechanisms regulating acetylcholine receptors at the neuromuscular junction

    Principal investigator: dr hab. Tomasz Jacek Prószyński

    Sieć Badawcza ŁUKASIEWICZ - PORT Polski Ośrodek Rozwoju Technologii

    Call: OPUS 19, Panel: NZ3

  36. 36. Application of machine learning based artificial intelligence to search for substances that modulate the activity of ROR…

    Principal investigator: dr hab. Marcin Marek Ratajewski

    Instytut Biologii Medycznej PAN

    Call: OPUS 17, Panel: NZ7

  37. 37. Prognostic value of platelet-derived microRNAs in patients with acute coronary syndrome treated with novel P2Y12 recepto…

    Principal investigator: dr hab. Aleksandra Gąsecka-van der Pol

    Warszawski Uniwersytet Medyczny, I Wydział Lekarski

    Call: PRELUDIUM 16, Panel: NZ7

  38. 38. Novel hybrid 5-HT6 serotonin receptor and SERT transporter ligands as a therapeutic perspective of behavioural and cogni…

    Principal investigator: dr Agata Siwek

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

    Call: SONATA 14, Panel: NZ7

  39. 39. New strategies in neuropathic pain pharmacotherapy based on the modulation of the functions of chemokine receptors CCR2 …

    Principal investigator: dr Klaudia Kwiatkowski

    Instytut Farmakologii PAN

    Call: PRELUDIUM 15, Panel: NZ7

  40. 40. Development of novel light-controllable azobenzene switches as molecular receptors for selective sensing and transport o…

    Principal investigator: dr Kajetan Jerzy Dąbrowa

    Instytut Chemii Organicznej Polska Akademia Nauk

    Call: SONATA 12, Panel: ST5

  41. 41. Synthesis of novel receptors, their application in chiral recognition of biologically relevant anions, and development o…

    Principal investigator: prof. Janusz Jurczak

    Instytut Chemii Organicznej Polska Akademia Nauk

    Call: OPUS 8, Panel: ST5

  42. 42. The role of sphingosine-1-phosphate (S1P) receptors signaling in animal model of Parkinson disease. Searching of novel t…

    Principal investigator: Joanna Agata Motyl

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

    Call: PRELUDIUM 5, Panel: NZ4

  43. 43. Binding isotope effects as new, unique tool for studies of receptor - ligand interactions

    Principal investigator: prof. Piotr Paneth

    Politechnika Łódzka

    Call: MAESTRO 1, Panel: ST4

  44. 44. Synthesis and marking the activity of new potential antagonists of receptors for excitatory amino acids which have the s…

    Principal investigator: prof. Aleksander Paweł Mazurek

    Warszawski Uniwersytet Medyczny, Wydział Farmaceutyczny

    Call: OPUS 1, Panel: NZ4

  45. 45. Chasing the HARE: elucidation of the binding mechanism of the new and unexplored ligandsof the Hyaluronic Acid Receptor …

    Principal investigator: dr Aleksandra Anna Twarda-Cłapa

    Politechnika Łódzka, Wydział Biotechnologii i Nauk o Żywności

    Call: SONATINA 4, Panel: NZ1

  46. 46. Novel multi-target ligands of aminergic GPCRs as pharmacological tools to study the pathomechanism of schzophrenia

    Principal investigator: dr hab. Agnieszka Anna Kaczor

    Uniwersytet Medyczny w Lublinie, Wydział Farmaceutyczny

    Call: OPUS 14, Panel: NZ7

  47. 47. Novel multi-target directed ligands combining cholinesterase inhibition and 5-HT6 antagonism - design, synthesis and pha…

    Principal investigator: dr hab. Anna Karolina Więckowska

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

    Call: SONATA 12, Panel: NZ7

  48. 48. Novel receptor materials for the construction of a bioelectronic nose for the rapid and efficient detection of lung canc…

    Principal investigator: prof. Wojciech Kamysz

    Gdański Uniwersytet Medyczny, Wydział Farmaceutyczny

    Call: OPUS 25, Panel: ST5

  49. 49. Searching for effective strategies to protect neuronal cells against hypoxia and ischemia: Identification of neuroprotec…

    Principal investigator: prof. Małgorzata Kajta

    Instytut Farmakologii PAN

    Call: OPUS 16, Panel: NZ7

  50. 50. The study of the role of mGluR8 in cancer cells - a potential target for new antitumor strategies

    Principal investigator: dr Danuta Jantas

    Instytut Farmakologii PAN

    Call: OPUS 3, Panel: NZ3

Graphic design and implementation: Jakub Piotrowski